ATE338123T1 - Akuter neuronal-induzierter liganden des calcium- bindenden protein-1 - Google Patents
Akuter neuronal-induzierter liganden des calcium- bindenden protein-1Info
- Publication number
- ATE338123T1 ATE338123T1 AT01936104T AT01936104T ATE338123T1 AT E338123 T1 ATE338123 T1 AT E338123T1 AT 01936104 T AT01936104 T AT 01936104T AT 01936104 T AT01936104 T AT 01936104T AT E338123 T1 ATE338123 T1 AT E338123T1
- Authority
- AT
- Austria
- Prior art keywords
- calcium
- binding protein
- acute neuronal
- induced ligand
- ligand
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00106110 | 2000-03-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE338123T1 true ATE338123T1 (de) | 2006-09-15 |
Family
ID=8168173
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01936104T ATE338123T1 (de) | 2000-03-21 | 2001-03-20 | Akuter neuronal-induzierter liganden des calcium- bindenden protein-1 |
Country Status (10)
Country | Link |
---|---|
US (1) | US20030148446A1 (da) |
EP (1) | EP1266008B1 (da) |
JP (1) | JP2003527848A (da) |
AT (1) | ATE338123T1 (da) |
CA (1) | CA2403436A1 (da) |
DE (1) | DE60122684T2 (da) |
DK (1) | DK1266008T3 (da) |
ES (1) | ES2271013T3 (da) |
PT (1) | PT1266008E (da) |
WO (1) | WO2001070771A2 (da) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007096854A1 (en) * | 2006-02-21 | 2007-08-30 | The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin | Compositions and methods for modulating an immune response |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1357041A (zh) * | 1999-06-22 | 2002-07-03 | 默克专利股份有限公司 | 头部创伤诱导的胞质钙结合蛋白 |
-
2001
- 2001-03-20 AT AT01936104T patent/ATE338123T1/de not_active IP Right Cessation
- 2001-03-20 ES ES01936104T patent/ES2271013T3/es not_active Expired - Lifetime
- 2001-03-20 US US10/239,079 patent/US20030148446A1/en not_active Abandoned
- 2001-03-20 DE DE60122684T patent/DE60122684T2/de not_active Expired - Fee Related
- 2001-03-20 EP EP01936104A patent/EP1266008B1/en not_active Expired - Lifetime
- 2001-03-20 WO PCT/EP2001/003149 patent/WO2001070771A2/en active IP Right Grant
- 2001-03-20 PT PT01936104T patent/PT1266008E/pt unknown
- 2001-03-20 CA CA002403436A patent/CA2403436A1/en not_active Abandoned
- 2001-03-20 DK DK01936104T patent/DK1266008T3/da active
- 2001-03-20 JP JP2001568972A patent/JP2003527848A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2001070771A3 (en) | 2002-05-02 |
JP2003527848A (ja) | 2003-09-24 |
CA2403436A1 (en) | 2001-09-27 |
US20030148446A1 (en) | 2003-08-07 |
DE60122684T2 (de) | 2007-08-23 |
DK1266008T3 (da) | 2006-11-27 |
PT1266008E (pt) | 2007-01-31 |
EP1266008B1 (en) | 2006-08-30 |
ES2271013T3 (es) | 2007-04-16 |
EP1266008A2 (en) | 2002-12-18 |
DE60122684D1 (de) | 2006-10-12 |
WO2001070771A2 (en) | 2001-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200400815T3 (tr) | AtorvastatinÁyarı@kalsiyumunÁyeniÁkristalÁformlarıÁveÁbunlarınÁhazırlanmasıÁiçinÁişlemlerÁayrıcaÁdiğerÁformlarınÁhazırlanmasıÁiçinÁyeniÁişlemler | |
ES2293973T3 (es) | Anticuerpos anti-ccr2 humanizados y metodos de uso de los mismos. | |
MXPA03000227A (es) | Compuestos novedosos. | |
BR0113820A (pt) | Compostos | |
WO2001066690A3 (en) | Novel compounds | |
EP2264174A3 (en) | Protein similar to neuroendocrine-specific protein, and encoding CDNA | |
ATE302413T1 (de) | Schnelle bestimmung des verhältnisses von biologischen molekülen | |
DE60013093D1 (de) | Methoden und kits zum sequenzieren von polypeptiden | |
WO2001072961A3 (en) | Novel compounds | |
ATE338123T1 (de) | Akuter neuronal-induzierter liganden des calcium- bindenden protein-1 | |
NO20000731D0 (no) | Neisseria-lactodweeinbindingsprotein | |
DE60117788D1 (de) | Menschliche wingless-änhliche gene | |
DE69918446D1 (de) | Polynucleotide and polypeptide basb033 aus neisseria meningitidis und ihre verwendungen | |
AU8394601A (en) | A novel member of the epha receptor family | |
DK1257573T3 (da) | Hidtil ukendt transskriptionsfaktor CARP-2 | |
WO2002004600A3 (en) | Novel compounds | |
WO2001004141A3 (en) | Seripancrin | |
NO20016340L (no) | Hodetraumeindusert cytoplasmatisk kalsiumbindende protein | |
DE60136643D1 (de) | Neuromedin u delta polypeptide | |
DE60041074D1 (de) | Spleissvariante des kopftrauma induzierten zytopla | |
EP0890646A3 (en) | HE2NW40 Serine Protease | |
DK1309690T3 (da) | MFQ-111, et humant GTPase-lignende protein | |
WO2001072963A3 (en) | Novel human uridine kinase | |
WO2002020562A3 (en) | Family member of inhibitor of apoptosis proteins | |
WO2001079492A3 (en) | Lipid binding protein 3 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1266008 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |